A detailed history of Aurora Private Wealth, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Aurora Private Wealth, Inc. holds 854 shares of LLY stock, worth $638,800. This represents 0.59% of its overall portfolio holdings.

Number of Shares
854
Previous 810 5.43%
Holding current value
$638,800
Previous $733,000 3.27%
% of portfolio
0.59%
Previous 0.64%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$772.14 - $960.02 $33,974 - $42,240
44 Added 5.43%
854 $757,000
Q2 2024

Jul 17, 2024

SELL
$724.87 - $909.04 $276,900 - $347,253
-382 Reduced 32.05%
810 $733,000
Q1 2024

Apr 22, 2024

BUY
$592.2 - $792.28 $36,716 - $49,121
62 Added 5.49%
1,192 $907,000
Q4 2023

Jan 30, 2024

BUY
$525.19 - $619.13 $124,470 - $146,733
237 Added 26.54%
1,130 $659,000
Q3 2023

Oct 18, 2023

BUY
$434.7 - $599.3 $75,637 - $104,278
174 Added 24.2%
893 $479,000
Q2 2023

Jul 20, 2023

SELL
$350.74 - $468.98 $11,925 - $15,945
-34 Reduced 4.52%
719 $337,000
Q1 2023

Apr 06, 2023

BUY
$310.63 - $364.82 $7,144 - $8,390
23 Added 3.15%
753 $259,000
Q4 2022

Jan 13, 2023

BUY
$321.55 - $374.67 $8,681 - $10,116
27 Added 3.84%
730 $267,000
Q3 2022

Oct 12, 2022

SELL
$296.48 - $337.87 $1.44 Million - $1.64 Million
-4,846 Reduced 87.33%
703 $227,000
Q2 2022

Jul 21, 2022

SELL
$278.73 - $327.27 $1.35 Million - $1.59 Million
-4,848 Reduced 87.37%
701 $227,000
Q2 2022

Jul 21, 2022

BUY
$278.73 - $327.27 $1.35 Million - $1.59 Million
4,850 Added 693.85%
5,549 $222,000
Q1 2022

Apr 14, 2022

BUY
$234.69 - $291.66 $164,048 - $203,870
699 New
699 $200,000
Q2 2020

Jul 27, 2020

SELL
$136.42 - $164.18 $232,596 - $279,926
-1,705 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $202,980 - $251,231
1,705 New
1,705 $236,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Aurora Private Wealth, Inc. Portfolio

Follow Aurora Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aurora Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aurora Private Wealth, Inc. with notifications on news.